Full Text
Cost Effectiveness of Empagliflozin in Patients with T2DM and High CV Risk in Canada

Abstract

Authors

SR Mettam H Bajaj AR Kansal P Kandaswamy

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×